TXI Reports First Quarter Results DALLAS, Oct. 2, 2013

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TXI Reports First Quarter Results

DALLAS, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Texas Industries, Inc. (NYSE: TXI ) today reported financial results for the quarter ended August 31, 2013. Results for the quarter were a net income of $.4 million or $.01 per share. Results for the quarter ended August 31, 2012 were a loss of $2.7 million or $.08 per share.

EBITDA from continuing operations for the August quarter equaled $37.8 million and EBITDA from continuing operations for the prior year's August quarter equaled $14.1 million. EBITDA for discontinued operations equaled $5.4 million in last year's August quarter. Continuing operations' EBITDA as a percentage of net sales for the August quarter this year and last year equaled 16.2% and 8.1%, respectively.

General Comments

"EBITDA increased $23.7 million on $58.6 million higher net sales," stated Mel Brekhus, Chief Executive Officer. "The improved results reflect the continuing improvement in construction activity in all of our markets."

"It is satisfying to start reaping the benefits from our recent strategic activities. So far, the start-up of our new kiln in central Texas has been the most successful of any I have been involved with in my career and we are realizing the benefits we expected from the expansion of our vertical integration footprint last spring. We continue to focus on doing everything we can to fully participate in the market recoveries under way, including accelerating the resumption of production from the first kiln in central Texas early next calendar year," added Brekhus.

A teleconference will be held October 3, 2013 at 10:00 Central Daylight Time to further discuss quarter results. A real-time webcast of the conference is available by logging on to TXI's website at www.txi.com .

The following is a summary of operating results for our business segments and certain other operating information related to our principal products.

Cement Operations

  Three months ended
  August 31, August 31,
In thousands except per unit 2013 2012
Operating Results    
Cement sales $ 104,426 $ 87,313
Other sales and delivery fees 10,322 9,892
Total segment sales 114,748 97,205
Cost of products sold 97,743 86,119
Gross profit 17,005 11,086
Selling, general and administrative (3,649) (3,544)
Other income, net 637 880
Operating profit $ 13,993 $ 8,422
Cement    
Shipments (tons) 1,314 1,119
Prices ($/ton) $ 79.43 $ 78.06
Cost of sales ($/ton) $ 67.29 $ 68.55

Three months ended August 31, 2013

Cement operating profit for the three-month periods ended August 31, 2013 and 2012 was $14.0 million and $8.4 million, respectively.

Total segment sales for the three-month period ended August 31, 2013 were $114.7 million compared to $97.2 million for the prior year period. Cement sales increased $17.1 million from the prior year period. Our Texas market area accounted for approximately 70% of cement sales in the current period compared to 67% of cement sales in the prior year period. Average cement prices increased 2% in our Texas market from the prior year period. Average cement prices increased 1% in our California market from the prior year period. Shipments increased 23% in our Texas market area and 8% in our California market area.

Cost of products sold for the three-month period ended August 31, 2013 increased $11.6 million from the prior year period primarily due to higher shipments, depreciation expense related to our new production line at our Hunter cement plant, repair and maintenance costs at our Texas plants, power and fuel costs, and emission allowance credits associated with our compliance with The California Global Warming Solutions Act of 2006, which took effect on January 1, 2013. Cement unit cost of sales decreased 2% from the prior year period as the impact of higher shipments were partially offset by the higher costs including depreciation, repair and maintenance, power and fuel, and emission allowance credits.

Selling, general and administrative expense for the three-month period ended August 31, 2013 increased $0.1 million from the prior year period.

Other income for the three-month period ended August 31, 2013 decreased $0.2 million from the prior year period.

Aggregates Operations

  Three months ended
  August 31, August 31,
In thousands except per unit 2013 2012
Operating Results    
Stone, sand and gravel sales  $ 35,670  $ 28,151
Delivery fees and other 13,488 12,830
Total segment sales 49,158 40,981
Cost of products sold 41,416 36,237
Gross profit 7,742 4,744
Selling, general and administrative (1,490) (1,008)
Other income, net 335 263
Operating profit  $ 6,587  $ 3,999
Stone, sand and gravel    
Shipments (tons) 4,447 3,914
Prices ($/ton)  $ 8.02  $ 7.19
Cost of sales ($/ton)  $ 6.33  $ 5.98

Previously, the aggregates segment included our expanded shale and clay lightweight aggregates operations which has been classified as discontinued operations in the prior period. Therefore, amounts for these operations are not included in the information presented.

Three months ended August 31, 2013

Aggregates operating profit for the three-month periods ended August 31, 2013 and 2012 was $6.6 million and $4.0 million, respectively.

Total segment sales for the three-month period ended August 31, 2013 were $49.2 million compared to $41.0 million for the prior year period. Stone, sand and gravel sales increased $7.6 million from the prior year period on 14% higher shipments and 12% higher average prices.

Cost of products sold for the three-month period ended August 31, 2013 increased $5.2 million from the prior year period primarily due to increased stone, sand and gravel shipments. Stone, sand and gravel unit costs increased 6% from the prior year period primarily due to the effect of geographic product mix partially offset by the effect of higher shipments.

Selling, general and administrative expense for the three-month period ended August 31, 2013 increased $0.5 million from the prior year period primarily due to higher bad debt expense.

Concrete Operations

  Three months ended
  August 31, August 31,
In thousands except per unit 2013 2012
Operating Results    
Ready-mix concrete sales  $ 98,234  $ 51,918
Delivery fees 286 127
Total segment sales 98,520 52,045
Cost of products sold 92,589 52,673
Gross profit (loss) 5,931 (628)
Selling, general and administrative (3,164) (2,690)
Other income, net 3,351 1,410
Operating profit (loss)  $ 6,118 $ (1,908)
Ready-mix concrete    
Shipments (cubic yards) 1,134 649
Prices ($/cubic yard)  $ 86.86  $ 80.08
Cost of sales ($/cubic yard)  $ 81.65  $ 80.97

Three months ended August 31, 2013

Concrete operating profit (loss) for the three-month periods ended August 31, 2013 and 2012 was $6.1 million and $(1.9) million, respectively.

Total segment sales for the three-month period ended August 31, 2013 were $98.5 million compared to $52.0 million for the prior year period. Segment sales increased $46.5 million from the prior year period due to the addition of the 42 ready-mix concrete plants acquired through an asset exchange in the prior year period, which accounts for 65% of the increase in shipments compared to the prior year period.   Pricing improved in virtually every market resulting in 8.5% higher average prices.

Cost of products sold for the three-month period ended August 31, 2013 increased $39.9 million from the prior year period as a result of the 42 additional ready-mix concrete plants acquired through an asset exchange in the prior year period, along with increased shipments from existing locations. Ready-mix concrete unit costs increased 1% from the prior year period primarily due to increased material and delivery costs partially offset by the effects of higher shipments.

Selling, general and administrative expense for the three-month period ended August 31, 2013 increased $0.5 million from the prior year period due to the addition of the 42 ready-mix concrete plants acquired through an asset exchange in the prior year period.

Other income for the three-month period ended August 31, 2013 increased $1.9 million from the prior year period primarily due to higher earnings from our joint venture of $0.5 million and increased gains from the disposal of assets of $1.2 million.

Corporate

  Three months ended
  August 31, August 31,
In thousands 2013 2012
Other income, net $ 1,534 $ 46
Selling, general and administrative (10,262) (10,317)
  $ (8,728) $ (10,271)

Three months ended August 31, 2013

Other income for the three-month period ended August 31, 2013 contains a gain of $1.3 million for a routine sale of real estate.

Selling, general and administrative expense for the three-month period ended August 31, 2013 remained relatively unchanged from the prior year period.

Interest

Interest expense incurred for the three-month period ended August 31, 2013 was $17.4 million. Interest expense incurred for the three-month period ended August 31, 2012 was $17.1 million, of which $9.3 million was capitalized in connection with our Hunter, Texas cement plant expansion project and $7.8 million was expensed.

Income Taxes

Income taxes for the interim periods ended August 31, 2013 and 2012 have been included in the accompanying financial statements on the basis of an estimated annual rate. The tax rate differs from the 35% federal statutory corporate rate primarily due to percentage depletion that is tax deductible, state income taxes and valuation allowances against deferred tax assets. The estimated annualized rate for continuing operations is 29.1% for fiscal year 2014 compared to (1.9)% for fiscal year 2013. We made no income tax payments and received no refunds in the three-month period ended August 31, 2013 and 2012. 

Certain statements contained in this quarterly report are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements may include the words "may," "will," "estimate," "intend," "continue," "believe," "expect," "plan," "anticipate," and other similar words. Such statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Potential risks and uncertainties include, but are not limited to, the impact of competitive pressures and changing economic and financial conditions on our business, the cyclical and seasonal nature of our business, the level of construction activity in our markets, abnormal periods of inclement weather, unexpected periods of equipment downtime, unexpected operational difficulties, changes in the cost of raw materials, fuel and energy, changes in cost or availability of transportation, changes in interest rates, the timing and amount of federal, state and local funding for infrastructure, delays in announced capacity expansions, ongoing volatility and uncertainty in the capital or credit markets, the impact of environmental laws, regulations and claims, changes in governmental and public policy, and the risks and uncertainties described in our reports on Forms 10-K, 10-Q and 8-K. Forward-looking statements speak only as of the date hereof, and we assume no obligation to publicly update such statements.

TXI is the largest producer of cement in Texas and a major cement producer in California. TXI is also a major supplier of construction aggregate, ready-mix concrete and concrete products.

Earnings before Interest, Taxes, Depreciation and Amortization* Three months ended
  August 31, August 31,
in thousands 2013 2012
Income before income taxes from continuing operations  $ 599  $ (7,533)
Depreciation 19,862 13,875
Interest Expense 17,371 7,777
EBITDA from continuing operations  $ 37,832  $ 14,119
EBITDA from discontinued operations**  --  5,362
Total EBITDA  $ 37,832  $ 19,481
     
EBITDA Margin    
EBITDA from continuing operations  $ 37,832  $ 14,119
Net Sales from continuing operations  $ 233,082  $ 174,523
EBITDA Margin 16.2% 8.1%
     
*A full reconciliation of EBITDA is continued on our website at www.txi.com .
** Expanded shale and clay operation's profit of $5.0 million plus depreciation expense of $0.4 million.

EBITDA represents income before interest, income taxes, depreciation and amortization and is presented because we believe it is a useful indicator of our performance and our ability to meet debt service and capital expenditure requirements. It is not, however, intended as an alternative measure of operating results or cash flow from operations as determined in accordance with generally accepted accounting principles. EBITDA is not necessarily comparable to similarly titled measures used by other companies.

(Unaudited)
CONSOLIDATED STATEMENTS OF OPERATIONS
TEXAS INDUSTRIES, INC. AND SUBSIDIARIES
     
  Three months ended
  August 31, August 31,
In thousands except per share 2013 2012
NET SALES  $ 233,082  $ 174,523
Cost of products sold 202,416 159,323
GROSS PROFIT 30,666 15,200
Selling, general and administrative 18,553 17,557
Interest expense 17,371 7,777
Other income, net (5,857) (2,599)
INCOME (LOSS) BEFORE INCOME TAXES FROM CONTINUING OPERATIONS 599 (7,535)
Income taxes (benefit) 170 (139)
NET INCOME (LOSS) FROM CONTINUING OPERATIONS  $ 429 $ (7,396)
NET INCOME FROM DISCONTINUED OPERATIONS — 4,738
NET INCOME (LOSS)  $ 429 $ (2,658)
NET INCOME (LOSS) PER SHARE FROM CONTINUING OPERATIONS:    
Basic  $ 0.02 $ (0.26)
Diluted  $ 0.01 $ (0.26)
NET INCOME PER SHARE FROM DISCONTINUED OPERATIONS:    
Basic $ —   $ 0.18
Diluted $ —   $ 0.18
NET INCOME (LOSS) PER SHARE:    
Basic  $ 0.02 $ (0.08)
Diluted  $ 0.01 $ (0.08)
AVERAGE SHARES OUTSTANDING    
Basic 28,578 27,998
Diluted 29,054 27,998

See notes to consolidated financial statements. 

(Unaudited)
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
TEXAS INDUSTRIES, INC. AND SUBSIDIARIES
     
  Three months ended
  August 31, August 31,
In thousands 2013 2012
Net Income (loss) $ 429 $ (2,658)
Other comprehensive income:    
     
Unrealized actuarial gain (loss) of defined benefit plans, net of tax expense (benefit) of $0 and $(32) — (55)
     
Reclassification of actuarial loss of defined benefit plans, net of tax benefit of $6 and $244, respectively. 9 423
Total other comprehensive income 9 368
Comprehensive income (loss) $ 438 $ (2,290)

See notes to consolidated financial statements.

CONSOLIDATED BALANCE SHEETS
TEXAS INDUSTRIES, INC. AND SUBSIDIARIES
     
  (Unaudited)  
  August 31, May 31,
In thousands except per share 2013 2013
ASSETS    
CURRENT ASSETS    
Cash and cash equivalents  $ 48,472  $ 61,296
Receivables – net 142,032 126,922
Inventories 107,678 105,054
Deferred income taxes and prepaid expenses 26,564 27,294
TOTAL CURRENT ASSETS 324,746 320,566
PROPERTY, PLANT AND EQUIPMENT    
Land and land improvements 172,488 172,780
Buildings 51,461 50,968
Machinery and equipment 1,648,894 1,647,460
Construction in progress 19,017 16,642
  1,891,860 1,887,850
Less depreciation and depletion 680,804 661,454
  1,211,056 1,226,396
OTHER ASSETS    
Goodwill 40,575 40,575
Real estate and investments 30,062 29,471
Deferred other charges 19,359 18,817
  89,996 88,863
   $ 1,625,798  $ 1,635,825
LIABILITIES AND SHAREHOLDERS' EQUITY    
CURRENT LIABILITIES    
Accounts payable  $ 69,617  $ 69,061
Accrued interest, compensation and other 49,541 62,336
Current portion of long-term debt 1,911 1,872
TOTAL CURRENT LIABILITIES 121,069 133,269
LONG-TERM DEBT 657,449 657,935
DEFERRED INCOME TAXES AND OTHER CREDITS 89,954 91,157
SHAREHOLDERS' EQUITY    
Common stock, $1 par value; authorized 100,000 shares; issued and outstanding 28,609 and 28,572 shares, respectively 28,609 28,572
Additional paid-in capital 517,947 514,560
Retained earnings 229,115 228,686
Accumulated other comprehensive loss (18,345) (18,354)
  757,326 753,464
   $ 1,625,798  $ 1,635,825

See notes to consolidated financial statements.

(Unaudited)
CONSOLIDATED STATEMENTS OF CASH FLOWS
TEXAS INDUSTRIES, INC. AND SUBSIDIARIES
     
  Three months ended
  August 31, August 31,
In thousands 2013 2012
OPERATING ACTIVITIES    
Net income (loss) $ 429 $ (2,658)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities    
Depreciation, depletion and amortization 19,862 14,216
Gain on asset disposals (3,069) (2,503)
Deferred income tax expense (benefit) 51 (3)
Stock-based compensation expense 2,298 2,766
Other – net (1,848) (3,026)
Changes in operating assets and liabilities    
Receivables – net (16,136) (14,013)
Inventories (2,824) 10,846
Prepaid expenses 278 1,099
Accounts payable and accrued liabilities (5,113) (4,632)
Net cash provided (used) by operating activities (6,072) 2,092
INVESTING ACTIVITIES    
Capital expenditures – expansions (7,125) (28,114)
Capital expenditures – other (5,373) (4,496)
Proceeds from asset disposals 4,319 3,578
Investments in life insurance contracts 934 146
Other – net — (59)
Net cash used by investing activities (7,245) (28,945)
FINANCING ACTIVITIES    
Debt payments (447) (1,028)
Stock option exercises 940 725
Net cash provided (used) by financing activities 493 (303)
Decrease in cash and cash equivalents (12,824) (27,156)
Cash and cash equivalents at beginning of period 61,296 88,027
Cash and cash equivalents at end of period  $ 48,472  $ 60,871

See notes to consolidated financial statements.

T. Lesley Vines, Jr. Corporate Controller & Treasurer Direct 972.647.6722 E-mail

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading